Role of Inflammation in Diabetic Retinopathy
Open accessThe DOI matches its Crossref record; 248 of the 249 references it cites were found in a registry or an index.
Abstract
Diabetic retinopathy is a common complication of diabetes and remains the leading cause of blindness among the working-age population. For decades, diabetic retinopathy was considered only a microvascular complication, but the retinal microvasculature is intimately associated with and governed by neurons and glia, which are affected even prior to clinically detectable vascular lesions. While progress has been made to improve the vascular alterations, there is still no treatment to counteract the early neuro-glial perturbations in diabetic retinopathy. Diabetes is a complex metabolic disorder, characterized by chronic hyperglycemia along with dyslipidemia, hypoinsulinemia and hypertension. Increasing evidence points to inflammation as one key player in diabetes-associated retinal perturbations, however, the exact underlying molecular mechanisms are not yet fully understood. Interlinked molecular pathways, such as oxidative stress, formation of advanced glycation end-products and increased expression of vascular endothelial growth factor have received a lot of attention as they all contribute to the inflammatory response. In the current review, we focus on the involvement of inflammation in the pathophysiology of diabetic retinopathy with special emphasis on the functional relationships between glial cells and neurons. Finally, we summarize recent advances using novel targets to inhibit inflammation in diabetic retinopathy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“and this might explain the difference in rates of intraocular inflammation between eyes with diabetic retinopathy and those with AMD, despite being treated with the same vector and concentration.”
From Ocular Gene Therapy: A Literature Review with Special Focus on Immune and Inflammatory Responses (2022) · cites this paper as [82]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Inflammatory processes are known to be integral in the pathogenesis of diabetic retinopathy,82”
From Ocular Gene Therapy: A Literature Review with Special Focus on Immune and Inflammatory Responses (2022) · cites this paper as [82]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–248 of 248
Intravitreal Triamcinolone Acetonide for Diabetic Retinopathy
Jonas, J. B. (2007) · KARGER eBooks · doi:10.1159/000098502 · Cited by 71
Liu, X., Ye, F., Xiong, H., Hu, D., Limb, G. A., Xie, T., Peng, L., Yang, W., Sun, Y., Zhou, M., et al. (2014) · Inflammation · doi:10.1007/s10753-014-9874-5 · Cited by 71
Wakabayashi, Y., Usui, Y., Okunuki, Y., Kezuka, T., Takeuchi, M., Gotô, H., & Iwasaki, T. (2010) · Retina · doi:10.1097/iae.0b013e3181bd2f44 · Cited by 71
Unterlauft, J. D., Eichler, W., Kuhne, K., Yang, X. M., Yafai, Y., Wiedemann, P., Reichenbach, A., & Claudepierre, T. (2012) · Neurochemical Research · doi:10.1007/s11064-012-0747-8 · Cited by 69
Vitreous Mediators in Retinal Hypoxic Diseases
dell’Omo, R., Semeraro, F., Bamonte, G., Cifariello, F., Romano, M. R., & Costagliola, C. (2013) · Mediators of Inflammation · doi:10.1155/2013/935301 · Cited by 68
Bonnin, S., Tadayoni, R., Erginay, A., Massin, P., & Dupas, B. (2015) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.14-15503 · Cited by 68
Lee, S.-J., Kim, M., & Kim, Y. (2015) · Indian Journal of Ophthalmology · doi:10.4103/0301-4738.158069 · Cited by 68
Stahel, M., Becker, M., Graf, N., & Michels, S. (2016) · Retina · doi:10.1097/iae.0000000000000701 · Cited by 67
Sun, W., Gerhardinger, C., Dagher, Z., Hoehn, T., & Lorenzi, M. (2005) · Diabetes · doi:10.2337/diabetes.54.12.3418 · Cited by 63
Chemokines in proliferative diabetic retinopathy and proliferative vitreoretinopathy
Asrar, A. A. E., Struyf, S., Kangave, D., Geboes, K. J., & Damme, J. V. (2008) · Acta Ophthalmologica · doi:10.1111/j.1755-3768.2008.5323.x · Cited by 61
Cui, B., Sun, J., Xiang, F., Liu, L., & Li, W. (2012) · Experimental Eye Research · doi:10.1016/j.exer.2012.02.013 · Cited by 59
Scott, I. U., Jackson, G. R., Quillen, D. A., Larsen, M., Klein, R., Liao, J., Holfort, S., Munch, I. C., & Gardner, T. W. (2014) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2014.93 · Cited by 59
Hang, H., Yuan, S., Yang, Q., Yuan, D., & Liu, Q. (2014) · Europe PMC (PubMed Central) · Cited by 58
Noma, H., Mimura, T., Yasuda, K., Motohashi, R., Kotake, O., & Shimura, M. (2017) · Ophthalmologica · doi:10.1159/000475603 · Cited by 56
Elevated protein carbonyl and HIF‐1α levels in eyes with proliferative diabetic retinopathy
Loukovaara, S., Koivunen, P., Inglés, M., Escobar, J., Vento, M., & Andersson, S. (2013) · Acta Ophthalmologica · doi:10.1111/aos.12186 · Cited by 55
Enhanced survival of retinal ganglion cells is mediated by Müller glial cell-derived PEDF
Unterlauft, J. D., Claudepierre, T., Schmidt, M., Müller, K., Yafai, Y., Wiedemann, P., Reichenbach, A., & Eichler, W. (2014) · Experimental Eye Research · doi:10.1016/j.exer.2014.08.004 · Cited by 53
Contribution of TNF receptor 1 to retinal neural cell death induced by elevated glucose
Costa, G. N., Vindeirinho, J., Cavadas, C., Ambrósio, A. F., & Santos, P. F. (2012) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2012.04.003 · Cited by 53
Lange, J., Yafai, Y., Reichenbach, A., Wiedemann, P., & Eichler, W. (2008) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.08-2201 · Cited by 50
Wang, S. (2009) · Archives of Ophthalmology · doi:10.1001/archophthalmol.2009.53 · Cited by 50
Gordon, W. C., & Bazan, N. G. (2013) · Current Eye Research · doi:10.3109/02713683.2013.827211 · Cited by 49
Effect of IL-1β on Survival and Energy Metabolism of R28 and RGC-5 Retinal Neurons
Abcouwer, S. F., Shanmugam, S., Gomez, P., Сакенович, Ш. С., Barber, A. J., LaNoue, K. F., Quinn, P. G., KESTER, M. A., & Gardner, T. W. (2008) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.07-1032 · Cited by 49
The Use of Intravitreal Etanercept in Diabetic Macular Oedema
Tsilimbaris, M. K., Panagiotoglou, T. D., Charisis, S. K., Anastasakis, A., Krikonis, T. S., & Christodoulakis, E. V. (2007) · Seminars in Ophthalmology · doi:10.1080/08820530701418243 · Cited by 49
Chalam, K. V., Grover, S., Sambhav, K., Balaiya, S., & Murthy, R. K. (2014) · Journal of Ophthalmology · doi:10.1155/2014/502174 · Cited by 48 · cited 1×
“Furthermore, IL-6 levels have been shown to positively correlate with retinal macular thickness [59].”
BackgroundAdamiec-Mroczek, J., Oficjalska−Młyńczak, J., & Misiuk‐Hojło, M. (2009) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2009.01.012 · Cited by 47
Kahtani, E. A., Xu, Z., Rashaed, S. A., Wu, L., Mahale, A., Tian, J., Abboud, E. B., Ghazi, N. G., Kozak, I., Gupta, V., et al. (2016) · Eye · doi:10.1038/eye.2016.246 · Cited by 47
Lee, C. A., Li, G., Patel, M. D., Petrash, J. M., Benetz, B. A., Veenstra, A., Amengual, J., Lintig, J. V., Burant, C. J., Tang, J. C. O., et al. (2013) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.13-11659 · Cited by 45
Muramatsu, D., Wakabayashi, Y., Usui, Y., Okunuki, Y., Kezuka, T., & Gotô, H. (2012) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-012-2024-6 · Cited by 45
Roles of elevated intravitreal IL-1β and IL-10 levels in proliferative diabetic retinopathy
Mao, C., & Yan, H. (2014) · Indian Journal of Ophthalmology · doi:10.4103/0301-4738.136220 · Cited by 45
Confocal Microscopy and Computer‐assisted Image Reconstruction of Astrocytes in the Mammalian Retina
Rungger‐Brändle, E., Messerli, J. M., Niemeyer, G., & Eppenberger, H. M. (1993) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1993.tb00963.x · Cited by 45
Effect of high glucose concentration on VEGF and PEDF expression in cultured retinal Müller cells
Mu, H., Zhang, X., Liu, J.-J., Li, D., & Feng, Z. (2008) · Molecular Biology Reports · doi:10.1007/s11033-008-9428-8 · Cited by 44
Matrix Metalloproteinase‐2 Expression and Apoptogenic Activity in Retinal Pericytes
Yang, R., Liu, H., WILLIAMS, I., & Chaqour, B. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1394.000 · Cited by 43
Neuroprotection for Diabetic Retinopathy
Imai, H., Singh, R. S., Fort, P. E., & Gardner, T. W. (2009) · Developments in ophthalmology · doi:10.1159/000223946 · Cited by 42
Self-citationRušňák, Š., Vrzalová, J., Sobotová, M., Hecová, L., Ricarova, R., & Topolčan, O. (2015) · Journal of Ophthalmology · doi:10.1155/2015/424783 · Cited by 41 · cited 2×
“Currently there are no widely accepted valid biomarkers to monitor DR severity or efficiently classify patients for optimal assessment of treatment efficacy, but reports indicate, that VEGF, HGF, IL-6 and MCP-1 intravitreal concentration increase with the progression of DR from the non-proliferative form to active PDR…”
BackgroundAlphaB-crystallin protects glial cells from hypertonic stress
Kegel, K. B., Iwaki, A., Iwaki, T., & Goldman, J. E. (1996) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1996.270.3.c903 · Cited by 41
Ghodasra, D. H., Fante, R. J., Gardner, T. W., Langue, M. A., Niziol, L. M., Besirli, C. G., Cohen, S. R., Dedania, V. S., Demirci, H., Jain, N., et al. (2016) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.15-18721 · Cited by 41
Tang, S., & Le-Ruppert, K. C. (1995) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/bf00177781 · Cited by 40
A specific phosphorylation regulates the protective role of αA-crystallin in diabetes
Rübsam, A., Dulle, J. E., Myers, A. M., Sakrikar, D. S., Green, K. M., Khan, N. W., Schey, K. L., & Fort, P. E. (2018) · JCI Insight · doi:10.1172/jci.insight.97919 · Cited by 40
Self-citationAizu, Y., Katayama, H., Takahama, S., Hu, J., Nakagawa, H., & Oyanagi, K. (2003) · Neuroreport · doi:10.1097/00001756-200311140-00012 · Cited by 38
El‐Asrar, A. M. A., Mohammad, G., Nawaz, M. I., & Siddiquei, M. M. (2014) · Current Eye Research · doi:10.3109/02713683.2014.982829 · Cited by 38
Modulation of Retinal Müller Cells by Complement Receptor C5aR
Cheng, L., Bu, H., Portillo, J. C., Li, Y., Subauste, C. S., Huang, S. S., Kern, T. S., & Lin, F. (2013) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.13-12428 · Cited by 37
Diabetic macular edema: it is more than just VEGF
Singer, M. A., Kermany, D., Waters, J., Jansen, M., & Tyler, L. (2016) · F1000Research · doi:10.12688/f1000research.8265.1 · Cited by 37 · cited 2×
“half of the patients respond to the treatment [10].”
BackgroundDecreased rhodopsin regeneration in diabetic mouse eyes.
Ostroy, S. E., Frede, S., Wagner, E. F., Gaitatzes, C. G., & Janle, E. M. (1994) · PubMed · Cited by 36
Feng, L., Ju, M., Lee, K. Y. V., Mackey, A. M., Evangelista, M., Iwata, D., Adamson, P., Lashkari, K., Foxton, R. H., Shima, D. T., et al. (2017) · American Journal Of Pathology · doi:10.1016/j.ajpath.2017.06.015 · Cited by 35
Wang, L., Deng, Q., Wu, X., Yu, J., Yang, X., & Zhong, Y. (2013) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12150 · Cited by 32
Oscillatory potentials in early diabetic retinopathy
van der Torren, K., & van Lith, G. (1989) · Documenta Ophthalmologica · doi:10.1007/bf00152764 · Cited by 24 · cited 1×
“Among those functional changes are deficits pointing to ganglion cells such as the pattern electroretinogram (ERG), altered microperimetric [32] and perimetric testing [11]; or more generally the inner retina such as increased implicit times and reduction in oscillatory potentials in the multifocal ERG (mfERG) [33].”
BackgroundCai, M., Zhang, X., Li, Y., & Xu, H. (2014) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2014-305690 · Cited by 22
Samuels, I. S., Portillo, J. C., Miao, Y., Kern, T. S., & Subauste, C. S. (2017) · Visual Neuroscience · doi:10.1017/s0952523817000074 · Cited by 10
Kim, M. (2016) · Endocrine Abstracts · doi:10.1530/endoabs.41.gp87 · Cited by 5
Research works printed but not linked: 1
- (2017, October 30). Allegro Ophthalmics Announces Positive Topline Results from Del Mar Phase 2b Trial Evaluating Luminate® in Patients with Diabetic Macular Edema. Available online: http://www.allegroeye.com/press.
Cited by
Inflammation in obesity, diabetes, and related disorders
Rohm, T. V., Meier, D. T., Olefsky, J. M., & Donath, M. Y. (2022) · Immunity · doi:10.1016/j.immuni.2021.12.013 · Cited by 2,066
Type 2 diabetes mellitus, oxidative stress and inflammation: examining the links.
Oguntibeju, O. O. (2019) · Europe PMC (PubMed Central) · Cited by 1,224
Rational Design of Immunomodulatory Hydrogels for Chronic Wound Healing
Kharaziha, M., Baidya, A., & Annabi, N. (2021) · Advanced Materials · doi:10.1002/adma.202100176 · Cited by 721
New insights into the mechanisms of diabetic complications: role of lipids and lipid metabolism
Eid, S., Sas, K. M., Abcouwer, S. F., Feldman, E. L., Gardner, T. W., Pennathur, S., & Fort, P. E. (2019) · Diabetologia · doi:10.1007/s00125-019-4959-1 · Cited by 468
Self-citationVEGFR1 signaling in retinal angiogenesis and microinflammation
Uemura, A., Fruttiger, M., D'Amore, P. A., De Falco, S., Joussen, A. M., Sennlaub, F., Brunck, L. R., Johnson, K. T., Lambrou, G. N., Rittenhouse, K. D., et al. (2021) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2021.100954 · Cited by 354
“Accordingly, the review begins by introducing the current biology of the VEGFR1 itself and in context with VEGFR2, Abbreviations AMD Age-related macular degeneration BRB Blood–retina barrier BRVO Branch retinal vein occlusion CCL2 CC chemokine ligand 2 CNV Choroidal neovascularization CRVO Central retinal vein occlusi…”
ResultInfluential
Metadata
- Authors
- Rübsam, A., Parikh, S., & Fort, P.
- Affiliations
- University of Michigan (US)
- Corresponding author
- Fort, Patrice
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2018-03-22
- Volume
- 19
- Issue
- 4
- Pages
- 942
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC5979417
- OpenAlex
- W2793401320
- Cited by
- 750
- References
- 249
- Citations by year
- 2026: 46 · 2025: 91 · 2024: 107 · 2023: 118 · 2022: 127 · 2021: 107 · 2020: 83 · 2019: 59 · 2018: 11
- FWCI
- 11.14
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, other-oa)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Eye Institute (R01-EY020895)
- Deutsche Forschungsgemeinschaft (RU 2020/2-1)
- Topics
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
- Health Sciences › Medicine › Ophthalmology › Ocular Diseases and Behçet’s Syndrome
- Keywords
- diabetic retinopathy, inflammation, neuroglial interactions, retinal microvasculature, oxidative stress, advanced glycation end products, vascular endothelial growth factor, glial cells, neurons, diabetes complications
- MeSH terms
- Animals, Astrocytes, Diabetic Retinopathy, Humans, Inflammation, Neurodegenerative Diseases, Ependymoglial Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.